Inventor · disambiguated record
Wu-Yan Zhang
Also filed as: ZHANG WU · ZHANG WU-YAN
7 granted patents·4 pending applications·15 citations·filing 2008–2022
78Inventor score
Files withTETRAPHASE PHARMACEUTICALS INC5LENZ HEINZ-JOSEF3BLACK DIAMOND THERAPEUTICS INC1SHANGHAI HANSOH BIOMEDICAL CO LTD1UNIV SOUTHERN CALIFORNIA1
Top patents by PatentIndex Score
11 records- 0185US10913712B2Tetracycline compoundsTETRAPHASE PHARMACEUTICALS INC·Filed 2019·Granted Feb 9, 2021·2 cites·4 claims
- 0284US10315992B2Tetracyline compoundsTETRAPHASE PHARMACEUTICALS INC·Filed 2017·Granted Jun 11, 2019·4 cites·19 claims
- 0384US9573895B2Tetracycline compoundsTETRAPHASE PHARMACEUTICALS INC·Filed 2013·Granted Feb 21, 2017·8 cites·10 claims
- 0466US10087157B2Semi-synthesis proceduresTETRAPHASE PHARMACEUTICALS INC·Filed 2015·Granted Oct 2, 2018·1 cites·11 claims
- 0562US10618879B2Semi-synthesis proceduresTETRAPHASE PHARMACEUTICALS INC·Filed 2018·Granted Apr 14, 2020·0 cites·18 claims
- 0657US2011178110A1Genotype and Expression Analysis for Use in Predicting Outcome and Therapy SelectionUNIV SOUTHERN CALIFORNIA·Filed 2009·Application pending·0 cites
- 0752US2024425492A1Polymorphs as erbb inhibitorsBLACK DIAMOND THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0852US2010099720A1Gene Polymorphisms as Sex-Specific Predictors in Cancer TherapyLENZ HEINZ-JOSEF·Filed 2008·Application pending·0 cites
- 0951US2023271969A1Nitrogen-containing fused ring derivative inhibitor, preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2021·Application pending·0 cites
- 1046US8278061B2Polymorphisms in the EGFR pathway as markers for cancer treatmentLENZ HEINZ-JOSEF·Filed 2008·Granted Oct 2, 2012·0 cites·5 claims
- 1146US8216781B2Gene polymorphisms as predictors of tumor progression and their use in cancer therapyLENZ HEINZ-JOSEF·Filed 2008·Granted Jul 10, 2012·0 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when Wu-Yan Zhang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →